AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Earnings are out

SY · NASDAQ · Medical - Healthcare Information Services

So-Young International (ADR)

Connects medical-aesthetics information, reservations, branded centers, and supply-chain services in China.

$2.83

Pre-market−0.09 (−3.08%)

At close$2.92(+21.67%)

In millions of USD, except per-share figures · converted from CNY at the latest rate

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	57	58	47	61	55	55	44	56	58	68	64	75
Cost of revenue	21	20	17	23	21	23	23	27	30	38	37	42
Gross profit	36	38	30	38	34	32	22	29	27	30	27	33
	36	38	35	37	33	121	28	36	38	45	35	40
Research & development	8	7	6	6	6	6	5	5	5	5	4	0
	29	32	29	30	27	35	23	31	33	40	32	36
Selling & marketing	21	19	17	20	17	20	15	20	19	0	0	0
General & administrative	7	13	13	11	10	15	8	12	13	0	0	0
Other expenses	0	0	0	0	0	80	0	0	0	0	0	4
Operating income	0	−1	−5	1	1	−89	−6	−7	−11	−15	−9	−6
	3	2	2	2	3	−1	1	2	1	−2	1	2
Interest income	2	2	2	2	2	1	1	1	1	1	1	0
Other non-operating income	0	−2	−2	−2	−3	−80	−1	−2	−1	2	−1	0
Income before tax	3	1	−3	3	3	−90	−5	−5	−9	−17	−8	−4
Income tax expense	0	−2	0	0	0	0	0	0	0	0	0	0
Net income from continuing operations	3	3	−3	3	3	−90	−5	−5	−10	−17	−7	−4
Other adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Net income	3	3	−3	3	3	−90	−5	−5	−10	−16	−7	−3
EPS, basic	$0.02	$0.02	−$0.02	$0.02	$0.02	−$0.68	−$0.04	−$0.04	−$0.07	−$0.12	−$0.06	−$0.03
EPS, diluted	$0.02	$0.02	−$0.02	$0.02	$0.02	−$0.68	−$0.04	−$0.04	−$0.07	−$0.12	−$0.06	−$0.03
Weighted average shares, basic	130	129	134	135	132	133	133	132	131	131	131	131
Weighted average shares, diluted	130	130	134	135	132	133	133	132	131	131	131	131
EBITDA	1	3	−2	4	5	−7	−5	−5	−9	−8	−8	−6
Depreciation & amortization	2	2	2	2	2	2	0	0	0	9	0	0
EBIT	0	1	−3	3	3	−9	−5	−5	−9	−17	−8	−6